VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MRXMarex Group Limited
$72.75$5.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMRXBalance Sheet

Marex Group Limited (MRX) Balance Sheet

13Y historyFree accessUpdated daily

The balance sheet shows extreme leverage with equity-to-assets of 0.04 and total assets ballooning to $42.1 billion by 2026Q2, indicating a thin capital buffer that may expose the firm to credit losses.

Income StatementBalance SheetCash FlowRatios

MRX Balance Sheet

Annual statement

MRX Balance Sheet

Marex Group Limited (MRX) balance sheet — 13-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Cash & Short Term Investments34.03B13.46B5.21B4.73B3.22B758.3M291.55M217.5M00000310.02M
Cash & Due from Banks3.85B6.38B2.56B1.48B910.1M712M291.55M217.5M160.73M89.22M188.18M158.26M159.1M310.02M
Short Term Investments4.6B7.08B2.66B3.25B2.31B46.3M00000000
Total Investments4.7B12.97B2.73B3.33B2.33B131.1M00000000
Investments Growth %546.16%374.22%-17.8%42.58%1679.63%---------
Long-Term Investments14.6B5.89B77.5M77M22M84.8M00000000
Accounts Receivables9.84B11.07B3.62B2.03B4.69B2.02B00000000
Goodwill & Intangibles354.3M335.4M233M219.6M181.1M230.4M212.75M187M142.83M141.75M141.51M141.74M144.88M147.22M
Goodwill261.8M237.4M176.5M163.6M155.5M208.9M198.4M179.18M140.97M140.97M140.97M140.97M143.97M145.6M
Intangible Assets92.5M98M56.5M56M25.6M21.5M14.35M7.83M1.86M776K537K771K911K1.62M
PP&E (Net)115.7M110.9M80.7M57.2M45.5M20.9M20.39M27.71M2.48M2.67M2.5M3.78M7.05M11.04M
Other Assets947.9M3.78B46.1M300.4M133.5M799.7M3.24B2.15B1.25B940.24M991.33M962.2M801.22M758.17M
Total Current Assets40.6B24.53B23.83B16.94B15.35B4.12B291.55M217.5M00000310.02M
Total Non-Current Assets1.52B10.15B484M675.6M389.7M1.14B3.48B2.36B1.39B1.08B1.14B1.11B953.14M916.43M
Total Assets42.13B34.68B24.31B17.61B15.74B5.26B3.77B2.58B1.39B1.08B1.14B1.11B953.14M1.23B
Asset Growth %197.18%42.62%38.05%11.86%199.05%39.76%46%84.96%28.6%-4.46%2.49%16.22%-22.28%-
Return on Assets (ROA)2.09%1.04%1.04%0.77%0.87%1.25%1.38%1.83%0.82%1.58%1.83%1.71%1.64%-0.42%
Accounts Payable11.16B11.78B7.74B4.92B6.65B3.29B00000000
Total Debt2.82B10.23B6.14B5.39B5.73B1.29B246.76M12.95M000000
Net Debt-1.03B3.86B3.58B3.9B4.82B578.1M-44.79M-204.56M-160.73M-89.22M-188.18M-158.26M-159.1M-310.02M
Long-Term Debt2.82B2.33B1.48B907.9M472.1M136.6M246.76M12.95M000000
Short-Term Debt8.67B7.81B4.58B4.43B5.22B1.13B00000000
Other Liabilities37.44B23.23B00002.95B2.07B1.01B712.27M761.5M734.13M595.85M0
Total Current Liabilities37.33B7.75B21.78B15.88B14.56B4.63B122.37M84.16M0000067.86M
Total Non-Current Liabilities40.26B25.66B1.56B951M504.3M156.8M3.2B2.08B1.01B712.27M761.5M734.13M595.85M0
Total Liabilities40.26B33.41B23.34B16.84B15.07B4.79B3.32B2.16B1.01B712.27M761.5M734.13M595.85M67.86M
Total Equity1.87B1.26B976.9M775.9M677.7M477.7M443.79M417.75M381.93M372.38M373.83M373.59M357.29M338.8M
Equity Growth %149.38%29.35%25.91%14.49%41.87%7.64%6.23%9.38%2.56%-0.39%0.07%4.56%5.46%-
Equity / Assets (Capital Ratio)4.44%3.64%4.02%4.41%4.3%9.07%11.78%16.19%27.38%34.33%32.93%33.73%37.49%27.62%
Return on Equity (ROE)52.95%27.51%24.87%17.61%15.86%12.26%10.17%9.1%2.69%4.69%5.48%4.83%5.13%-1.51%
Book Value per Share24.7116.6012.9810.749.576.757.326.896.306.146.176.165.895.59
Tangible BV per Share20.0212.199.887.707.013.493.813.813.943.803.833.823.503.16
Common Stock100K100K100K100K100K100K23K23K21K176.24M21K21K20.59K20.59K
Additional Paid-in Capital227.2M227.2M300.2M231.9M231.9M134.3M134.33M134.33M134.52M134.31M134.3M134.29M134.29M0
Retained Earnings1.2B982M722.4M555.3M455.3M346.6M132.64M107.01M72.28M62.13M64.63M64.14M46.49M28.62M
Accumulated OCI497.8M15.4M-22.6M-1.6M-1.7M-3.3M176.8M176.39M175.12M-295K174.88M175.14M176.5M175.87M
Treasury Stock-57.3M-58.5M-23.2M-9.8M-7.9M000000000
Preferred Stock097.6M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Elevated leverage and NII deficit

Leverage-Fueled Asset Surge

Marex's total assets ballooned from $5.3 billion in 2021Q4 to $42.1 billion in 2026Q2, a 694% expansion, while equity grew only 298%, compressing the equity-to-assets ratio from 0.09 to 0.04 as per the company's reported balance sheets.

This trajectory indicates that growth is overwhelmingly driven by leverage accumulation rather than organic capital formation, with the balance sheet expanding through acquisitions and increased client-related liabilities. The quality of this asset growth warrants scrutiny, as it appears highly sensitive to market conditions and counterparty flows rather than stable, deposit-funded lending.

Thin Capital Buffer Under Pressure

With an equity-to-assets ratio of just 0.04 and a reported debt-to-equity ratio of 8.10, Marex's capital position appears minimally sized to absorb potential losses on its $42.1 billion balance sheet, according to the latest 2026Q2 financial data.

The razor-thin equity cushion leaves little room for error, particularly given the firm's exposure to volatile commodity markets and the cyclical nature of its earnings. While the high ROE of 17.1% reflects efficient use of capital, investors should monitor whether this leverage is sustainable through a period of market stress or potential regulatory tightening in clearing.

Structural NII Deficit Amplifies Leverage Risk

Marex reported negative net interest income in six of the last ten quarters, including a $261.2 million deficit in 2026Q2, suggesting the firm's balance sheet may be structurally mismatched and vulnerable to shifts in funding costs or asset yields.

This persistent NII drain, combined with the extreme leverage, creates a fragile financial profile where a downturn could rapidly erode capital. The negative NIM implies that the interest expense on client funds and debt is outpacing returns on cash and securities, a dynamic that could intensify if interest rates rise or client balances decline.

Client Funds Dominate Cash Position

Although cash and equivalents totaled $3.9 billion in 2026Q2, the presence of substantial client segregated balances suggests that a significant portion is not freely available for corporate use, as inferred from the firm's balance sheet structure and business model.

This concentration in restricted cash means Marex's true liquidity position is likely much tighter than headline figures imply. The firm must maintain robust access to wholesale funding or revolving credit facilities to meet potential client margin calls, especially during periods of high commodity volatility.

MRX — Frequently Asked Questions

Quick answers to the most common questions about buying MRX stock.

What are the total assets of Marex Group Limited (MRX)?

As of 2025, Marex Group Limited (MRX) had total assets of $34.68B including $24.53B in current assets.

How much debt does Marex Group Limited (MRX) have?

Marex Group Limited (MRX) carries total debt of $10.23B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Marex Group Limited?

Marex Group Limited (MRX) has total shareholders' equity (book value) of $1.26B ($16.60 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Marex Group Limited's current ratio and liquidity?

Marex Group Limited (MRX) reported a current ratio of 3.16x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.